TME remodeling orchestrates metabolic plasticity through stromal-immune crosstalk, wherein CAFs secrete oncometabolites like lactate and kynurenine that subvert CD8+ T cell effector functions while licensing PD-L1 expression on tumor cells [79, 80]. Here, CD8A is linked to neoplasm.